The Chemours Company (NYSE:CC) Receives $24.11 Average Price Target from Analysts

Shares of The Chemours Company (NYSE:CC) have been given a consensus rating of “Hold” by the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $23.56.

Several research firms recently issued reports on CC. Royal Bank of Canada restated an “outperform” rating and issued a $25.00 price target on shares of Chemours in a research note on Thursday, December 12th. Morgan Stanley cut their target price on Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. Mizuho cut their target price on Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. The Goldman Sachs Group cut their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Finally, Truist Financial began coverage on Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 target price for the company.

Hedge Funds Weigh In On Chemours

Institutional investors have recently modified their holdings of the business. Corient Private Wealth LLC increased its holdings in Chemours by 4.7% in the 4th quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company’s stock worth $227,000 after purchasing an additional 604 shares in the last quarter. KBC Group NV increased its holdings in Chemours by 19.5% in the 3rd quarter. KBC Group NV now owns 4,468 shares of the specialty chemicals company’s stock worth $91,000 after purchasing an additional 728 shares in the last quarter. Blue Trust Inc. increased its holdings in Chemours by 166.9% in the 3rd quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 731 shares in the last quarter. GAMMA Investing LLC increased its holdings in Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 765 shares in the last quarter. Finally, HUB Investment Partners LLC increased its holdings in Chemours by 1.4% in the 4th quarter. HUB Investment Partners LLC now owns 58,250 shares of the specialty chemicals company’s stock worth $984,000 after purchasing an additional 821 shares in the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Stock Performance

CC opened at $17.13 on Monday. The business has a fifty day simple moving average of $18.17 and a 200 day simple moving average of $18.94. The company has a market capitalization of $2.56 billion, a PE ratio of 34.26 and a beta of 1.81. Chemours has a 1 year low of $15.10 and a 1 year high of $29.83. The company has a debt-to-equity ratio of 6.05, a current ratio of 1.73 and a quick ratio of 0.92.

Chemours (NYSE:CC) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a return on equity of 29.48% and a net margin of 1.34%. Research analysts expect that Chemours will post 1.21 EPS for the current year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be issued a dividend of $0.25 per share. The ex-dividend date is Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.84%. Chemours’s dividend payout ratio (DPR) is currently 200.00%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.